Literature DB >> 18265003

Hepatocyte growth factor modulates Sertoli-Sertoli tight junction dynamics.

A Catizone1, G Ricci, M Galdieri.   

Abstract

In mammalian testes Sertoli cells form tight junctions whose function is fundamental for the maintenance of a normal spermatogenesis. Hepatocyte growth factor (HGF) is a cytokine influencing the cellular tight junctions either in normal or in tumor cells. We have previously demonstrated that HGF is expressed in the rat testis and influences many functional activities of somatic and germ cells. We now report that HGF decreases the levels of testicular occludin and influences the position of the molecule in the tight junctions as demonstrated by confocal microscopy analysis. In fact in the presence of the factor occludin was mainly localized in the suprabasal region of the tubules whereas in its absence occludin was prevalently localized in the basal region. Occludin production is known to be regulated by different cytokines including TGFbeta. We have investigated the role of HGF in the regulation of the levels of TGFbeta and we report that HGF significantly increases the amount of the active fraction of the factor without affecting the amount of the total TGFbeta. Urokinase type plasminogen activator (uPA) is closely related with the tight junctions and is one of the molecules able to activate the inactive TGF-beta. We found that HGF significantly increases the amount of uPA present in the testis suggesting that HGF regulates the amount of active TGFbeta via uPA levels. In conclusion we report that in the testis HGF regulates Sertoli-Sertoli tight junctions inducing a reduction and redistribution of occludin possibly modulating the levels of uPA and active TGFbeta. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18265003     DOI: 10.1002/jcp.21400

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.

Authors:  Robert M Sargis; Ravi Salgia
Journal:  Am J Clin Oncol       Date:  2015-10       Impact factor: 2.339

2.  p70 S6 kinase and actin dynamics: A perspective.

Authors:  Carman K M Ip; Alice S T Wong
Journal:  Spermatogenesis       Date:  2012-01-01

3.  Lithium improves survival of PC12 pheochromocytoma cells in high-density cultures and after exposure to toxic compounds.

Authors:  Cinzia Fabrizi; Stefania De Vito; Francesca Somma; Elena Pompili; Angela Catizone; Stefano Leone; Paola Lenzi; Francesco Fornai; Lorenzo Fumagalli
Journal:  Int J Cell Biol       Date:  2014-01-20

4.  Microenvironment promotes tumor cell reprogramming in human breast cancer cell lines.

Authors:  Fabrizio D'Anselmi; Maria Grazia Masiello; Alessandra Cucina; Sara Proietti; Simona Dinicola; Alessia Pasqualato; Giulia Ricci; Gabriella Dobrowolny; Angela Catizone; Alessandro Palombo; Mariano Bizzarri
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 5.  Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?

Authors:  Xiangdong Wang; Ka Li; Hong Chen; Diane Wang; Yong Zhang; Chunxue Bai
Journal:  J Cell Mol Med       Date:  2010-01-30       Impact factor: 5.310

6.  HGF Modulates Actin Cytoskeleton Remodeling and Contraction in Testicular Myoid Cells.

Authors:  Angela Catizone; Giulia Ricci; Maria Caruso; Michela Galdieri; Katia Corano Scheri; Virginia Di Paolo; Rita Canipari
Journal:  Biomedicines       Date:  2015-01-28

7.  PA1 participates in the maintenance of blood-testis barrier integrity via cooperation with JUN in the Sertoli cells of mice.

Authors:  Bo Liu; Chao Liu; Binfang Ma; Ruidan Zhang; Zhiwei Zhao; Sai Xiao; Wanjun Cao; Yanjie Ma; Guozhang Zhu; Wei Li; Zhen Li
Journal:  Cell Biosci       Date:  2022-04-04       Impact factor: 7.133

Review 8.  Pleiotropic Activities of HGF/c-Met System in Testicular Physiology: Paracrine and Endocrine Implications.

Authors:  Giulia Ricci; Angela Catizone
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-03       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.